Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

被引：0
|
作者：
Robert S. Zhang
Allison Padegimas
Kathleen M. Murphy
Peter T. Evans
Carli J. Peters
Christopher M. Domenico
Mahesh K. Vidula
Paul J. Mather
Marisa Cevasco
Roger B. Cohen
Joseph R. Carver
Rupal P. O’Quinn
机构：
[1] University of Pennsylvania,Department of Medicine
[2] University of Pennsylvania,Division of Cardiovascular Medicine
[3] University of Pennsylvania,Division of Infectious Disease
[4] University of Pennsylvania,Department of Pharmacy
[5] University of Pennsylvania,Department of Cardiothoracic Surgery
[6] University of Pennsylvania,Division of Hematology
来源：
Cardio-Oncology | / 7卷
关键词：
Immune checkpoint inhibitor; Myocarditis; Infliximab; Cardio‐oncology; Pembrolizumab; Nivolumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
    Zhang, Robert S.
    Padegimas, Allison
    Murphy, Kathleen M.
    Evans, Peter T.
    Peters, Carli J.
    Domenico, Christopher M.
    Vidula, Mahesh K.
    Mather, Paul J.
    Cevasco, Marisa
    Cohen, Roger B.
    Carver, Joseph R.
    O'Quinn, Rupal P.
    CARDIO-ONCOLOGY, 2021, 7 (01)
  • [2] Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
    Wang, Cong
    Lin, Jinyi
    Wang, Yan
    Hsi, David H.
    Chen, Jiahui
    Liu, Tianshu
    Zhou, Yuhong
    Ren, Zhenggang
    Zeng, Zhaochong
    Cheng, Leilei
    Ge, Junbo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] Immune checkpoint inhibitor myocarditis
    Raikhelkar, Jayant
    Uriel, Nir
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (03) : 303 - 306
  • [4] Relevance of surveillance manual for the early detection of immune checkpoint inhibitor-induced myocarditis: A case series
    Oyakawa, Takuya
    Muraoka, Nao
    Iida, Kei
    Fujita, Ayano
    Yokoyama, Koichi
    Ishikawa, Hiroshi
    Murakami, Haruyasu
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2024, 11 (11)
  • [5] Treatment of Immune Checkpoint Inhibitor-associated Myocarditis
    Heemelaar, Julius C.
    Louisa, Maria
    Neilan, Tomas G.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (05) : 384 - 391
  • [6] Refractory constrictive pericarditis caused by an immune checkpoint inhibitor properly managed with infliximab: a case report
    Moriyama, Shohei
    Fukata, Mitsuhiro
    Tatsumoto, Ryoma
    Kono, Mihoko
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2021, 5 (01)
  • [7] Treatment of steroid-refractory immune checkpoint inhibitor induced intestinal pseudo obstruction with infliximab
    Dai, Cong
    Huang, Yu-Hong
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (07) : 383 - 384
  • [8] Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
    Alexander, James L.
    Ibraheim, Hajir
    Sheth, Bhavisha
    Little, Jessica
    Khan, Muhammad Saheb
    Richards, Camellia
    Hunter, Nikki
    Chauhan, Dharmisha
    Ratnakumaran, Raguprakash
    McHugh, Kathleen
    Pinato, David J.
    Nathan, Paul
    Choy, Julia
    Crusz, Shanthini M.
    Furness, Andrew
    Turajlic, Samra
    Pickering, Lisa
    Larkin, James
    Teare, Julian P.
    Papa, Sophie
    Speight, Ally
    Sharma, Anand
    Powell, Nick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [9] Myocarditis induced by immune checkpoint inhibitor therapy
    Baig, Muhammad Akbar
    Brambl, Wells
    Heuser, William
    CLINICAL TOXICOLOGY, 2022, 60 : 118 - 119
  • [10] A case of gastritis caused by immune checkpoint inhibitor treated with infliximab
    Itsukage, Shizu
    Kume, Noriko
    Tajima, Aki
    Okazaki, Takashi
    Tsuta, Koji
    Tanizaki, Hideaki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 454 - 459
12345